相关实验视频
Updated: Jul 24, 2025

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.8K
心脏 Amyloidosis:最先进的审查状态
1Department of Medicine, Temple University Hospital, Philadelphia, PA, USA.
Journal of geriatric cardiology : JGC
|July 3, 2023
概括
心脏 Amyloidosis (CA),包括跨素 (ATTR) 和轻链 (AL) 类型,越来越多地被认可和可治疗. 诊断包括心电图,回声,核磁共振和特定测试,如ATTR的骨光学,而治疗则针对潜在原因.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 遗传学 遗传学 是一个
背景情况:
- 心脏粉症 (CA) 是由心脏中的粉样纤维沉积引起的.
- 关键的亚型包括跨氨酸心肌粉症 (ATTR) 和免疫球蛋白轻链心肌粉症 (AL).
- ATTR进一步分为野生型 (wtATTR) 和遗传型 (hATTR) 形式,基于转胺基因突变.
研究的目的:
- 审查不断发展的心脏粉症的理解和管理.
- 突出 ATTR 和 AL 氨基粉症的诊断方法和治疗策略.
主要方法:
- 对CA的临床表现和诊断方式的审查.
- 讨论ATTR和AL氨基粉症的当前和新兴治疗干预措施.
主要成果:
- 由于改进的诊断和治疗方法,CA正变得越来越受认可.
- 诊断途径包括心电图,心声图,心脏MRI,骨扫描 (ATTR) 和组织学 (AL).
- 血清生物标志物有助于确定ATTR和AL的疾病严重程度.
结论:
- 心脏粉症是一种可治疗的疾病,从罕见和无法治疗的转变为越来越多的认可.
- 对于ATTR和AL都存在有效的管理策略,针对疾病机制.
- 早期临床线索和适当的诊断工作对于及时诊断和治疗至关重要.
相关概念视频
Cardiomyopathy I: Introduction and Classification
19
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
19
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K

